Home > Documents in Process > Neuroprotective therapies for neonatal hypoxic-ischemic brain injury - a contemporary update. > print

001     282628
005     20251212153123.0
024 7 _ |a 10.1016/j.semperi.2025.152128
|2 doi
024 7 _ |a pmid:40887401
|2 pmid
024 7 _ |a 0146-0005
|2 ISSN
024 7 _ |a 1558-075X
|2 ISSN
037 _ _ |a DZNE-2025-01364
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Sabir, Hemmen
|0 P:(DE-2719)9000732
|b 0
|e Last author
|u dzne
245 _ _ |a Neuroprotective therapies for neonatal hypoxic-ischemic brain injury - a contemporary update.
260 _ _ |a Philadelphia, Pa.
|c 2025
|b Saunders
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1765549833_25184
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Neonatal encephalopathy of hypoxic-ischemic origin remains a leading cause of global neonatal mortality. Over the past decades, various neuroprotective strategies have been explored; however, therapeutic hypothermia remains the only clinically approved intervention to date. This review outlines emerging and adjunctive treatment modalities beyond therapeutic hypothermia and emphasizes the critical need for robust and reproducible translational research to bridge the gap between preclinical findings and clinical applications.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Hypoxic-ischemic encephalopathy (HIE)
|2 Other
650 _ 7 |a Neuroprotection
|2 Other
650 _ 7 |a Newborn
|2 Other
650 _ 7 |a Neuroprotective Agents
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Hypoxia-Ischemia, Brain: therapy
|2 MeSH
650 _ 2 |a Infant, Newborn
|2 MeSH
650 _ 2 |a Hypothermia, Induced: methods
|2 MeSH
650 _ 2 |a Neuroprotective Agents: therapeutic use
|2 MeSH
650 _ 2 |a Neuroprotection
|2 MeSH
650 _ 2 |a Asphyxia Neonatorum: therapy
|2 MeSH
650 _ 2 |a Asphyxia Neonatorum: complications
|2 MeSH
773 _ _ |a 10.1016/j.semperi.2025.152128
|g Vol. 49, no. 8, p. 152128 -
|0 PERI:(DE-600)2174573-0
|n 8
|p 152128 -
|t Seminars in perinatology
|v 49
|y 2025
|x 0146-0005
856 4 _ |u https://pub.dzne.de/record/282628/files/DZNE-2025-01364.pdf
|y Restricted
856 4 _ |u https://pub.dzne.de/record/282628/files/DZNE-2025-01364.pdf?subformat=pdfa
|x pdfa
|y Restricted
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9000732
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
|d 2024-12-20
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-20
920 1 _ |0 I:(DE-2719)5000032
|k AG Sabir
|l Neonatal Neuroscience
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)5000032
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21